Olea, Rodica-Alis (Date of defense: 2024-01-15)
[eng] In the last decades, great research effort was focused towards designing nanocarriers for cancer therapy. However, nanoparticle translation from basic research to the clininc has proven to be a ...
Playà Albinyana, Heribert (Date of defense: 2024-04-29)
[eng] Chronic lymphocytic leukemia (CLL) is a prevalent form of leukemia among adults in western countries, marked by a monoclonal mature CD19+ CD5+ B cell expansion in the peripheral blood, secondary ...
Garcia Garijo, Andrea (Date of defense: 2023-05-26)
[eng] Adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TILs) can medi- ate tumor regression in patients with metastatic melanoma. Retrospective studies of TIL products from responders and ...
Hernández Carro, Claudia (Date of defense: 2024-03-19)
[eng] Prostate and colorectal cancer are among the cancer types with the highest recurrence and mortality rates. The emergence of drug resistance poses a considerable challenge for effective treatment, ...
Creus Bachiller, Edgar (Date of defense: 2024-03-13)
[eng] Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are aggressive soft-tissue sarcomas. They usually appear in the clinical context of Neurofibromatosis type 1 (NF1), however, they also occur at a ...
Aguado Flor, Ester (Date of defense: 2024-04-12)
[eng] During radiotherapy (RT) some healthy tissues are irradiated inevitably causing side effects, without being able to predict nowadays which patients will develop this toxicity. To date, the biomarker ...